Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / April / SEE Program Strengthens Adherence
Glaucoma News Health Economics and Policy

SEE Program Strengthens Adherence

Personalized glaucoma coaching program boosts medication adherence in randomized trial

4/3/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions

Clinical Report: SEE Program Strengthens Adherence

Overview

The SEE program, a motivational interviewing-based coaching intervention, significantly improved medication adherence and reduced glaucoma-related distress compared to standard education. This randomized clinical trial involved 235 adults with glaucoma and demonstrated a marked increase in adherence rates and a decrease in distress scores over six months.

Background

Medication adherence is a critical aspect of managing chronic conditions like glaucoma, where poor adherence can lead to adverse outcomes. The SEE trial addresses this issue by implementing a structured coaching program that combines personalized education and motivational interviewing. Understanding effective adherence strategies is essential for improving patient outcomes and reducing healthcare costs.

Data Highlights

GroupAdherence Rate (%)Distress Score Change
SEE Intervention77.6Improved
Control Group58.0Moderate

Key Findings

  • The SEE program improved electronically monitored adherence from 63.9% at baseline to 77.6% at six months.
  • 54.9% of SEE participants achieved at least 80% adherence, compared to 23.7% in the control group.
  • Participants in the SEE group experienced a significant reduction in glaucoma-related distress scores.
  • The intervention's effects were consistent across various sensitivity analyses.
  • The SEE program utilized a web-based system for personalized education and structured coaching.

Clinical Implications

Healthcare providers should consider implementing structured, motivational interviewing-based coaching programs to enhance medication adherence among glaucoma patients. Such interventions can lead to improved patient outcomes and reduced distress, ultimately benefiting both patients and the healthcare system.

Conclusion

The SEE program demonstrates that personalized coaching can effectively improve medication adherence and reduce distress in glaucoma patients. Future research should explore the long-term impacts of such interventions on clinical outcomes.

References

  1. JAMA Ophthalmology, 2023 -- SEE Program Strengthens Adherence
  2. optometric management — Utilizing Staff for Patient Adherence
  3. Ophthalmology Management — Medication Adherence Interventions That Work
  4. The ASCO Post — UC Davis Comprehensive Cancer Center Tailors Pilot Program to Help Patients Adhere to Oral Chemotherapy
  5. Drugs - Real World Outcomes — Pharmacist-Led Strategies to Enhance Adherence to Specialty Medications: Protocol for a Randomized Controlled Trial
  6. Utilizing Staff for Patient Adherence
  7. Medication Adherence Interventions That Work
  8. UC Davis Comprehensive Cancer Center Tailors Pilot Program to Help Patients Adhere to Oral Chemotherapy
  9. Advancing glaucoma care: What's new in the 6th edition of the European Glaucoma Society guidelines
  10. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial - PubMed
  11. Interventions for Glaucoma Medication Adherence Improvement: A Network Meta-analysis of Randomized Controlled Trials - PubMed

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: